Related Experiment Video
Updated: Mar 19, 2026

Digital Home-Monitoring of Patients after Kidney Transplantation: The MACCS Platform
Published on: April 12, 2021
Effectiveness and content analysis of interventions to enhance medication adherence in hypertension: a systematic
Eimear C Morrissey1, Hannah Durand2, Robby Nieuwlaat3
1School of Psychology, National University of Ireland, Galway, Ireland. e.morrissey6@nuigalway.ie.
Insights
Improving medication adherence in hypertension is crucial for cardiovascular health. This review evaluates interventions, identifying barriers and facilitators to enhance treatment effectiveness and patient outcomes.
Area of Science:
- Pharmacology and Cardiovascular Health
- Public Health and Patient Adherence
Background:
- Pharmacological treatment of hypertension significantly reduces cardiovascular morbidity and mortality.
- However, medication adherence rates among treated hypertensive patients range from 20% to 50%, compromising treatment efficacy.
- This highlights the need for effective interventions to improve adherence.
Purpose of the Study:
- To systematically review and evaluate the effectiveness of medication adherence interventions specifically for hypertension.
- To explore barriers and facilitators targeted by these interventions.
- To investigate the relationship between targeted theoretical domains and the effect size on blood pressure control.
Main Methods:
- This study is an update to the Cochrane Review by Nieuwlaat et al. (2014).
- A systematic literature search will be conducted, with independent screening and data extraction by two authors.
- Methodological quality will be assessed using the Cochrane Collaboration Risk of Bias Tool, followed by meta-analysis and identification of theoretical factors using the Theoretical Domains Framework.
Main Results:
- This section is to be populated upon completion of the review and meta-analysis.
Conclusions:
- This review will provide quantitative data on the effectiveness of hypertension medication adherence interventions.
- It aims to identify which theoretical domains are most associated with successful interventions.
- The findings will also highlight domains that have been underutilized in intervention development for hypertension management.
Background:
Hypertension control through pharmacological treatment has led to substantial benefits in the prevention of morbidity and mortality from cardiovascular diseases. However, evidence from a number of studies suggests that as many as 50 to 80 % of patients treated for hypertension have low adherence to their treatment regimen. The objective of this systematic review is to evaluate the effectiveness of medication adherence interventions for hypertension. In addition, we aim to explore what barriers and facilitators in the interventions may have been targeted and how these might be related to the effect size on blood pressure (BP).
Methods:
This review is a hypertension-specific update to the previous Cochrane Review by Nieuwlaat et al. (2014) on interventions to enhance medication adherence. A systematic literature search will be carried out, and two authors will independently screen titles and abstracts for their eligibility for inclusion and independently extract data from the selected studies and assess the methodological quality using the Cochrane Collaboration Risk of Bias Tool. A meta-analysis will be conducted, and additionally, theoretical factors in interventions will be identified using the Theoretical Domains Framework.
Discussion:
This review will generate new information by quantitatively evaluating the effectiveness of adherence interventions for hypertension and potentially identify which theoretical domains are associated with more effective interventions and which domains have not been the subject of intervention development.
Systematic Review Registration:
PROSPERO CRD42016033358.
Related Concept Videos
Hypertension V: Nursing Management
Drug Therapy
Antianxiety Medications
Hypertension IV: Drug Therapy and Lifestyle Modifications
Antihypertensive Drugs: Direct Renin Inhibitors
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
